Therapeutic Efficacy of Lysophosphatidylcholine in Severe Infections Caused by Acinetobacter baumannii

Due to the significant increase in antimicrobial resistance of Acinetobacter baumannii, immune system stimulation to block infection progression may be a therapeutic adjuvant to antimicrobial treatment. Lysophosphatidylcholine (LPC), a major component of phospholipids in eukaryotic cells, is involve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Smani, Younes, Domínguez-Herrera, Juan, Ibáñez-Martínez, José, Pachón, Jerónimo
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468695/
https://ncbi.nlm.nih.gov/pubmed/25896698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04986-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars